Supplements
curcumin improves cognition
In plain terms: Does turmeric boost memory or brain function?
Part of: 🧪 turmeric & curcumin
The evidence doesn't back it. Controlled human trials are mixed-to-null, and reviews of memory supplements rate curcumin's evidence as weak. Not established.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Despite the 'brain food' reputation, controlled human trials are mixed-to-null: some show small vascular/mood effects but the cognitive-performance results in healthy and clinical adults are inconsistent, and reviews of memory supplements rate the evidence as weak. Not established.
The evidence (9)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Victoria-Montesinos D et al 2026 · study_type: meta-analysis | meta-analysis | mixed | low | SR/MA of 18 RCTs of Zingiberaceae-derived interventions (including curcumin) in adults; pooled SMD=0.57 (0.13-1.02) for memory-related outcomes, but no significant effect for executive function/processing speed, global cognition, or attenti |
| Kumari A et al 2026 · study_type: observational | observational | mixed | moderate | Critical narrative review of trial data (via ClinicalTrials.gov + PubMed) for 9 dietary bioactives in AD; reports curcumin's Phase III trials did not meet primary cognitive endpoints, alongside DHA and tricaprilin. |
| Gimblet 2024 · Antioxidants (Basel) | RCT | contradicts | moderate | RCT in chronic kidney disease: curcumin's effects on vascular and cognitive function were not clearly beneficial. |
| Sliwinska 2021 · Rocz Panstw Zakl Hig | observational | mixed | low | Review of nutrition in Alzheimer's: curcumin's cognitive benefit remains unproven in controlled human trials. |
| Sivamaruthi BS et al 2026 · study_type: observational | observational | mixed | low | Narrative review (not systematic) of RCTs on curcumin (Longvida, Theracurmin, CurQfen) and cognition; reports improvements in working memory, attention, mood in older adults but heterogeneous results across studies. No new n or meta-analyti |
| Wang W et al 2025 · study_type: meta-analysis | meta-analysis | supports | moderate | Meta-analysis of 9 RCTs (12 comparisons, 501 subjects): curcumin significantly improved global cognitive function vs placebo (SMD 0.82, 95% CI 0.19-1.45); effect significant only with duration ≥24 weeks, age ≥60, or Asian populations. |
| Santos-Parker 2018 · Nutr Healthy Aging | RCT | contradicts | moderate | RCT in healthy middle-aged/older adults: curcumin improved some vascular markers but cognitive-function effects were limited/inconsistent. |
| Yu L et al 2025 · study_type: meta-analysis | meta-analysis | mixed | moderate | Systematic review/meta-analysis: 25 preclinical rodent AD studies (n=572) showed consistent memory improvement; but 10 human RCTs (531 participants) showed no significant effect on global cognition (SMD=0.14, CI -0.78 to 1.07), with only su |
| Hersant 2023 · CNS Drugs | observational | mixed | low | Review of over-the-counter memory supplements: evidence for curcumin improving memory is weak/insufficient. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.